Lonny Green

Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settings

Current Medical Research and Opinion · 2018 · 13 citations

Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the…

Neurourology and Urodynamics · 2018 · 4 citations